Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa randomized placebo-controlled trial of MK-0773 in elderly women with sarcopenia
2007-002383-95Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Sarcopenia comparing MK-0773 with Placebo (2 arms). Primary endpoints: Change from baseline in bilateral leg press strength at Month 6 and Change from baseline in total lean body mass at Month 6. Started Jun 2007; status: completed.
02
Drugs
MK-0773
03
Conditions
Sarcopenia
Beyond the preview
Go deeper on 2007-002383-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002383-95.